Article
Apolipoprotein E genotypes are associated with lipid-lowering responses to statin treatment in diabetes: a Go-DARTS study.
Pharmacogenetics and genomics - 1 Apr 2008
Donnelly Louise A, Palmer Colin N A, Whitley Adrian L, Lang Chim Choy, Doney Alex S F, Morris Andrew D, Donnan Peter T
Abstract excerpt
BACKGROUND: Apolipoprotein E (APOE) genotypes have been associated with variations in plasma-lipid levels and with response to statins, although the influence of APOE on the response to statins remains controversial, especially in patients with diabetes. We sought to evaluate the association of the APOE genotype with the low-density lipoprotein cholesterol (LDLc)-lowering response to statins, in a large...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
